Capricor Therapeutics, Inc.
(CAPR - NASDAQ)
35,10 USD
📋 Profilo Aziendale

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders.

|